✦ LIBER ✦

Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy

✍ Scribed by Jens Ingwersen; Orhan Aktas; Patrick Kuery; Bernd Kieseier; Alexey Boyko; Hans-Peter Hartung

Book ID: 113541998
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 472 KB
Volume: 142
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2011.05.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fingolimod for Multiple Sclerosis: Mecha

Fingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions

✍ Matthias Mehling; Ludwig Kappos; Tobias Derfuss 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 125 KB

Mechanisms of fingolimod's efficacy and

Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis

✍ Jeffrey A. Cohen; Jerold Chun 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

Mechanism of Action of Oral Fingolimod (

Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis

✍ Chun, Jerold; Hartung, Hans-Peter 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 1001 KB

Efficacy of fingolimod treatment in rela

Efficacy of fingolimod treatment in relapsing multiple sclerosis patients in clinical practice: A multicenter experience

✍ Alroughani, R.; Al Hashel, J.; Behbahani, R.; Ahmed, S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Interferon- mechanisms of action in mult

Interferon- mechanisms of action in multiple sclerosis

✍ Dhib-Jalbut, S.; Marks, S. 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 442 KB

Pregnancy outcomes in the clinical devel

Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis

✍ Karlsson, G.; Francis, G.; Koren, G.; Heining, P.; Zhang, X.; Cohen, J. A.; Kapp 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 394 KB